HUP9902181A3 - Acylated n-hydroxy methyl thalidomide prodrugs with immunomodulator action - Google Patents

Acylated n-hydroxy methyl thalidomide prodrugs with immunomodulator action

Info

Publication number
HUP9902181A3
HUP9902181A3 HU9902181A HUP9902181A HUP9902181A3 HU P9902181 A3 HUP9902181 A3 HU P9902181A3 HU 9902181 A HU9902181 A HU 9902181A HU P9902181 A HUP9902181 A HU P9902181A HU P9902181 A3 HUP9902181 A3 HU P9902181A3
Authority
HU
Hungary
Prior art keywords
acylated
hydroxy methyl
immunomodulator
action
prodrugs
Prior art date
Application number
HU9902181A
Other languages
English (en)
Hungarian (hu)
Original Assignee
Gruenenthal Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Gruenenthal Gmbh filed Critical Gruenenthal Gmbh
Publication of HUP9902181A2 publication Critical patent/HUP9902181A2/hu
Publication of HUP9902181A3 publication Critical patent/HUP9902181A3/hu

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00—Technologies relating to chemical industry
    • Y02P20/50—Improvements relating to the production of bulk chemicals
    • Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Veterinary Medicine (AREA)
  • Immunology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Pyrrole Compounds (AREA)
HU9902181A 1996-04-09 1997-03-22 Acylated n-hydroxy methyl thalidomide prodrugs with immunomodulator action HUP9902181A3 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19613976A DE19613976C1 (de) 1996-04-09 1996-04-09 Thalidomid-Prodrugs mit immunmodulatorischer Wirkung

Publications (2)

Publication Number Publication Date
HUP9902181A2 HUP9902181A2 (hu) 2000-04-28
HUP9902181A3 true HUP9902181A3 (en) 2002-11-28

Family

ID=7790778

Family Applications (1)

Application Number Title Priority Date Filing Date
HU9902181A HUP9902181A3 (en) 1996-04-09 1997-03-22 Acylated n-hydroxy methyl thalidomide prodrugs with immunomodulator action

Country Status (12)

Country Link
US (1) US6417197B1 (cg-RX-API-DMAC7.html)
EP (1) EP0892794B1 (cg-RX-API-DMAC7.html)
JP (1) JP2000508298A (cg-RX-API-DMAC7.html)
CN (1) CN1102931C (cg-RX-API-DMAC7.html)
AT (1) ATE212989T1 (cg-RX-API-DMAC7.html)
AU (1) AU707144B2 (cg-RX-API-DMAC7.html)
DE (2) DE19613976C1 (cg-RX-API-DMAC7.html)
DK (1) DK0892794T3 (cg-RX-API-DMAC7.html)
ES (1) ES2171923T3 (cg-RX-API-DMAC7.html)
HU (1) HUP9902181A3 (cg-RX-API-DMAC7.html)
PT (1) PT892794E (cg-RX-API-DMAC7.html)
WO (1) WO1997037988A1 (cg-RX-API-DMAC7.html)

Families Citing this family (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE19613976C1 (de) * 1996-04-09 1997-11-20 Gruenenthal Gmbh Thalidomid-Prodrugs mit immunmodulatorischer Wirkung
AU3224997A (en) * 1996-05-29 1998-01-05 Prototek, Inc Prodrugs of thalidomide and methods for using same as modulators of t-cell function
HU228769B1 (en) * 1996-07-24 2013-05-28 Celgene Corp Substituted 2(2,6-dioxopiperidin-3-yl)phthalimides and -1-oxoisoindolines and their use for production of pharmaceutical compositions for mammals to reduce the level of tnf-alpha
DE19743968C2 (de) * 1997-10-06 2002-07-11 Gruenenthal Gmbh Intravenöse Applikationsform von Thalidomid zur Therapie immunologischer Erkrankungen
DE69834668T2 (de) * 1997-11-18 2007-01-11 Celgene Corp. Substituierte 2-(2,6-dioxo-3-fluoropiperidine-3-yl)-isoindoline und ihre Verwendung zum reduzieren des TNF-alpha spiegels
US5955476A (en) * 1997-11-18 1999-09-21 Celgene Corporation Substituted 2-(2,6-dioxo-3-fluoropiperidin-3-yl)-isoindolines and method of reducing inflammatory cytokine levels
AU4515001A (en) * 1999-12-02 2001-06-18 Regents Of The University Of Michigan, The Compositions and methods for locally treating inflammatory diseases
US7091353B2 (en) 2000-12-27 2006-08-15 Celgene Corporation Isoindole-imide compounds, compositions, and uses thereof
EP1389203B8 (en) * 2001-02-27 2010-03-10 The Governement of the United States of America, represented by The Secretary Department of Health and Human services Analogs of thalidomide as angiogenesis inhibitors
CN100488959C (zh) * 2003-03-27 2009-05-20 天津和美生物技术有限公司 水溶性的酞胺哌啶酮衍生物
WO2005016326A2 (en) * 2003-07-11 2005-02-24 The Government Of The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services Analogs of thalidomide as potential angiogenesis inhibitors
CN100398534C (zh) * 2003-09-15 2008-07-02 天津和美生物技术有限公司 合成酞胺哌啶酮及其衍生物的方法
US7973057B2 (en) * 2003-09-17 2011-07-05 The United States Of America As Represented By The Department Of Health And Human Services Thalidomide analogs
US8952895B2 (en) 2011-06-03 2015-02-10 Apple Inc. Motion-based device operations
US7423150B2 (en) * 2003-10-16 2008-09-09 Novartis Ag Substituted benzazoles and methods of their use as inhibitors of Raf kinase
ITMI20041113A1 (it) * 2004-06-01 2004-09-01 Antibioticos Spa Processo per la sintesi della talidomide
US20070155791A1 (en) * 2005-12-29 2007-07-05 Zeldis Jerome B Methods for treating cutaneous lupus using aminoisoindoline compounds
WO2007120669A1 (en) 2006-04-13 2007-10-25 The Government Of The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services Tetrahalogenated compounds useful as inhibitors of angiogenesis
EP3354646A1 (en) * 2008-10-29 2018-08-01 Celgene Corporation Isoindoline compounds for use in the treatment of cancer
US8927725B2 (en) 2011-12-02 2015-01-06 The United States Of America, As Represented By The Secretary, Department Of Health And Human Services Thio compounds
TWI782395B (zh) * 2016-01-08 2022-11-01 美商西建公司 抗增生化合物，及其醫藥組合物及用途
US20200199097A1 (en) * 2017-08-21 2020-06-25 Nanjing Noratech Pharmaceuticals Co., Ltd Pomalidomide derivative and preparation method therefor
CN111499610A (zh) * 2019-01-31 2020-08-07 南京诺瑞特医药科技有限公司 泊马度胺前体药物盐的多晶型物
EP3771711A1 (en) 2019-07-29 2021-02-03 Bayer Animal Health GmbH Pyrazole derivatives for controlling arthropods

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU1531492A (en) * 1991-02-14 1992-09-15 Rockefeller University, The Method for controlling abnormal concentration tnf alpha in human tissues
ES2098505T3 (es) * 1991-04-17 1997-05-01 Gruenenthal Chemie Nuevos derivados de la talidomida, su procedimiento de preparacion y composiciones farmaceuticas que los contienen.
DE19613976C1 (de) * 1996-04-09 1997-11-20 Gruenenthal Gmbh Thalidomid-Prodrugs mit immunmodulatorischer Wirkung

Also Published As

Publication number Publication date
US6417197B1 (en) 2002-07-09
HK1017350A1 (en) 1999-11-19
PT892794E (pt) 2002-07-31
WO1997037988A1 (de) 1997-10-16
AU2505297A (en) 1997-10-29
DK0892794T3 (da) 2002-04-15
AU707144B2 (en) 1999-07-01
CN1102931C (zh) 2003-03-12
ATE212989T1 (de) 2002-02-15
EP0892794A1 (de) 1999-01-27
JP2000508298A (ja) 2000-07-04
HUP9902181A2 (hu) 2000-04-28
DE19613976C1 (de) 1997-11-20
DE59706313D1 (de) 2002-03-21
EP0892794B1 (de) 2002-02-06
CN1215397A (zh) 1999-04-28
ES2171923T3 (es) 2002-09-16

Similar Documents

Publication Publication Date Title
HUP9902181A3 (en) Acylated n-hydroxy methyl thalidomide prodrugs with immunomodulator action
PL331286A1 (en) Modified oligosaccharides
GB9714462D0 (en) Multi-venting molding apparatus
GB2317140B (en) Molded article retrieval apparatus
GB2317161B (en) Box
EP0963431A4 (en) NEW FabH
SI0892794T1 (en) Acylated n-hydroxy methyl thalidomide prodrugs with immunomodulator action
GB2311090B (en) Enclosure device
GB9713860D0 (en) Enclosure component
GB2343409B (en) Improved molded article retrieval apparatus
GB9613380D0 (en) Electro-magnetic pallet stripper
GB2333574B (en) Movement-controlling device
PL323271A1 (en) Box
PL325529A1 (en) Deviations eliminating device
GB9609660D0 (en) Charge-transfer device
GB2287811B (en) Polling
GB2313080B (en) A stripping device
KR200173933Y1 (en) Micro-switch
TW311331U (en) Improved seedlings-growing box arrangement device
GB9612071D0 (en) Box
GB9623027D0 (en) Box
AU129906S (en) Bin enclosure
SG75893A1 (en) Clean box
GB9611660D0 (en) Enclosure
TW303793U (en) Modified mold remover structure

Legal Events

Date Code Title Description
FD9A Lapse of provisional protection due to non-payment of fees